Skip to main
  1. Stocks
  2. Lixte Biotechnology Holdings I
  3. Market Cap
NMAD

NMAD Market Capitalization Overview

Market Cap: $56.99M as of Oct 29, 2026

$56.99M
$3.39M (5.60%)past month
As of Oct 29, 2026, NMAD has a market capitalization of $56.99M. Over the past 30 days, its market cap has decreased by -5.85%, while in the last 12 months, it has increased by 81.22%.

Market capitalization represents the total value of Lixte Biotechnology Holdings I as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

NMAD Market Cap Formula = Stock Price * Shares Outstanding

The market cap of NMAD helps investors assess the company's size and compare it with competitors for better investment decisions.

NMAD Market Cap & Key Trends

See Lixte Biotechnology Holdings I’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in NMAD

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NMAD Market Cap History

DateMarket CapChange
Oct 1, 2026$62.16M-5.85%
Sep 1, 2026$66.02M-19.07%
Aug 3, 2026$81.58M-38.83%
Jul 1, 2026$133.36M+49.37%
Jun 1, 2026$89.29M+128.03%
May 1, 2026$39.16M+59.43%
Apr 1, 2026$24.56M+4.61%
Mar 2, 2026$23.48M-17.60%
Feb 2, 2026$28.50M-7.29%
Jan 2, 2026$30.74M+31.40%

NMAD End of Year Market Cap History

DateMarket CapChange
2026$56.99M+81.22%
2025$31.46M+588.92%
2024$4.57M-13.63%
2023$5.29M-37.62%
2022$8.48M-48.20%
2021$16.36M—

FAQs About Lixte Biotechnology Holdings I (NMAD) Market Cap

As of Oct 29, 2026, the market capitalization of NMAD is $56.99M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Lixte Biotechnology Holdings I’s market capitalization has decreased by -5.60%, changing from $60.38M to $56.99M as of Oct 29, 2026.

In the last 3 months, Lixte Biotechnology Holdings I’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Lixte Biotechnology Holdings I’s market capitalization increased from $4.57M in January to $31.46M in December, reflecting a 588.92% change.

In the past five years, NMAD has had a compound annual growth rate (CAGR) of 13.97% in market capitalization. This means its market cap has grown at an average rate of 13.97% per year.

Lixte Biotechnology Holdings I (NMAD)


NMAD Market Cap & Key Trends

See Lixte Biotechnology Holdings I’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in NMAD

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover NMAD stock data and trends